Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

NCT02428218 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Feasibility

Conditions

Relapsing-Remitting Multiple Sclerosis
Relapsing Forms of Multiple Sclerosis

Interventions

DRUG: dimethyl fumarate
DRUG: Placebo

Sponsor

Biogen